WINSLOW GARRETT (General Counsel) sold 9.7% of their position (245.00 shares) of DAMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $7.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/8/2026ACC: 0001193125-26-297818
Officer· General Counsel
Since May 2021
-245.00
Net shares
Net seller
$7.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
680.00 acquired · 925.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+680.00
Price / share
—
Trade value
—
% of position
36.7%
7/3/2026
1.85K→2.53K
Common Stock
Direct
Shares
−245.00
Price / share
$29.98
Trade value
$7.35K
% of position
9.7%
7/6/2026
2.53K→2.29K
Total
Net shares
+435.00
Net value
-$7.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/3/2026 | M · Option Exercise | +680.00 | — | — | 36.7% | 1.85K | 2.53K |
| Common Stock Direct | 7/6/2026 | S · Sale | −245.00 | $29.98 | $7.35K | 9.7% | 2.53K | 2.29K |
| Total | +435.00 | -$7.35K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
680.00 shares
Shares
−680.00
Strike price
Held after
640.00
Exercisable
—
7/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock680.00 shares | 7/3/2026 | M · Option Exercise | −680.00 | — | 640.00 |